Cargando…

PK-PD integration of enrofloxacin and cefquinome alone and in combination against Klebsiella pneumoniae using an in vitro dynamic model

Introduction: Klebsiella pneumoniae is classified as a critical pathogen in both animals and humans and infections can be fatal in chickens resulting in substantial economic losses. However, the misuse of antibiotics can also lead to drug resistance and a potential transmission chain between animals...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Yanzhe, Ji, Xuan, Zhang, Fuhui, Zhang, Suiling, Deng, Qin, Ding, Huanzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587432/ https://www.ncbi.nlm.nih.gov/pubmed/37869750 http://dx.doi.org/10.3389/fphar.2023.1226936

Ejemplares similares

Correlation of PK/PD Indices with Resistance Selection for Cefquinome against Staphylococcus aureus in an In Vitro Model
por: Li, Yafei, et al.
Publicado: (2016)

Kill Rate and Evaluation of Ex Vivo PK/PD Integration of Cefquinome Against Actinobacillus pleuropneumoniae
por: Zhang, Longfei, et al.
Publicado: (2021)

Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model
por: Xiong, Mingpeng, et al.
Publicado: (2016)

In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis
por: Xiao, Xia, et al.
Publicado: (2015)

Microdialysis Determination of Cefquinome Pharmacokinetics in Murine Thigh From Healthy, Neutropenic, and Actinobacillus pleuropneumoniae-Infected Mice
por: Zhang, Longfei, et al.
Publicado: (2019)

PK/PD integration of florfenicol alone and in combination with doxycycline against Riemerella anatipestifer
por: Zhang, Huilin, et al.
Publicado: (2022)

Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle
por: Ahmad, Ijaz, et al.
Publicado: (2015)

Cefquinome-loaded microsphere formulations against Klebsiella pneumonia infection during experimental infections
por: Qu, Shaoqi, et al.
Publicado: (2018)

Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against Actinobacillus pleuropneumoniae
por: Zhang, Longfei, et al.
Publicado: (2020)

The PK/PD Interactions of Doxycycline against Mycoplasma gallisepticum
por: Zhang, Nan, et al.
Publicado: (2016)

PK-PD Analysis of Marbofloxacin against Streptococcus suis in Pigs
por: Lei, Zhixin, et al.
Publicado: (2017)

In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model
por: Zhang, Bingxu, et al.
Publicado: (2014)

Editorial: Pharmacokinetics, pharmacodynamics (PK/PD) of antibiotics: A reality check
por: Zeitlinger, Markus, et al.
Publicado: (2023)

Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model
por: Gu, Mengxiao, et al.
Publicado: (2015)

Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against Escherichia coli in Pigs
por: Lei, Zhixin, et al.
Publicado: (2017)

The PK/PD Integration and Resistance of Tilmicosin against Mycoplasma hyopneumoniae
por: Huang, Zilong, et al.
Publicado: (2020)

Relationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model
por: Zhang, Nan, et al.
Publicado: (2018)

PK-PD Integration Modeling and Cutoff Value of Florfenicol against Streptococcus suis in Pigs
por: Lei, Zhixin, et al.
Publicado: (2018)

In silico genome-scale metabolic modeling and in vitro static time-kill studies of exogenous metabolites alone and with polymyxin B against Klebsiella pneumoniae
por: Chung, Wan Yean, et al.
Publicado: (2022)

Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back to Move Forward
por: Landersdorfer, Cornelia B., et al.
Publicado: (2021)

In vitro susceptibility of four antimicrobials against Riemerella anatipestifer isolates: a comparison of minimum inhibitory concentrations and mutant prevention concentrations for ceftiofur, cefquinome, florfenicol, and tilmicosin
por: Li, Yafei, et al.
Publicado: (2016)

Pharmacokinetic/pharmacodynamic integration of tilmicosin against Pasteurella multocida in a piglet tissue cage model
por: Chen, Yuqin, et al.
Publicado: (2023)

Dispositions of enrofloxacin and its major metabolite ciprofloxacin in Thai swamp buffaloes
por: RUENNARONG, Nitwarat, et al.
Publicado: (2015)

Population PK/PD modelling of meropenem in preterm newborns based on therapeutic drug monitoring data
por: Zyryanov, Sergey, et al.
Publicado: (2023)

The PK–PD Relationship and Resistance Development of Danofloxacin against Mycoplasma gallisepticum in An In Vivo Infection Model
por: Zhang, Nan, et al.
Publicado: (2017)

Optimal Regimens and Clinical Breakpoint of Avilamycin Against Clostridium perfringens in Swine Based on PK-PD Study
por: Huang, Anxiong, et al.
Publicado: (2022)

Future insights of pharmacological prevention for AKI post cardiopulmonary bypass surgery (based on PK/PD approach)
por: Permeisari, Dias
Publicado: (2022)

Clinical Efficacy and Residue Depletion of 10% Enrofloxacin Enteric-Coated Granules in Pigs
por: Lei, Zhixin, et al.
Publicado: (2017)

Preparation of Cefquinome Sulfate Proliposome and its Pharmacokinetics in Rabbit
por: FU, Qiang, et al.
Publicado: (2013)

PK/PD Study of Mycophenolate Mofetil in Children With Systemic Lupus Erythematosus to Inform Model-Based Precision Dosing
por: Chen, Yewei, et al.
Publicado: (2020)

Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for Streptococcus suis Infection
por: Zhou, Yu-Feng, et al.
Publicado: (2017)

S17.3 PK/PD in the treatment of hospital-acquired pneumonia
Publicado: (2005)

Emergence and Mechanism of Resistance of Tulathromycin Against Mycoplasma hyopneumoniae in a PK/PD Model and the Fitness Costs of 23S rRNA Mutants
por: Xia, Xirui, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Escherichia coli
por: Jitaree, Kamonchanok, et al.
Publicado: (2019)

Synergistic Combination of Polymyxin B and Enrofloxacin Induced Metabolic Perturbations in Extensive Drug-Resistant Pseudomonas aeruginosa
por: Lin, Yu-Wei, et al.
Publicado: (2019)

Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against Acinetobacter baumannii in Patients with Hospital-Acquired Pneumonia
por: Zhou, Yingjie, et al.
Publicado: (2022)

Development of Stability-Indicating Methods for Cefquinome Sulphate
por: Shantier, Shaza W., et al.
Publicado: (2013)

Dose Optimization of Aditoprim-Sulfamethoxazole Combinations Against Trueperella pyogenes From Patients With Clinical Endometritis by Using Semi-mechanistic PK/PD Model
por: Maan, Muhammad Kashif, et al.
Publicado: (2021)

A Potent Antibiotic Combination of Linezolid and Polymycin B Nonapeptide Against Klebsiella pneumoniae Infection In Vitro and In Vivo
por: Huang, Ting, et al.
Publicado: (2022)

Stability of Ceftiofur Sodium and Cefquinome Sulphate in Intravenous Solutions
por: Dołhań, Agnieszka, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dirk51jhq5n862k58offf0imnv